drug
Trump Administration Joins Medicare Drug Negotiations
WASHINGTON — The Trump administration on Tuesday celebrated drug price reductions it achieved through a program created by Democrats — despite Republicans’ long-standing antipathy toward the policy. The Inflation Reduction Act, a 2022 law supported only by Democrats and signed into law by then-President Biden, allowed the Trump administration to obtain lower prices on 15 […]
Roche suffers another blow as Indian Supreme Court allows sale of generics of its expensive rare disease drug
In a case billed as profiteering against patients, India’s Supreme Court rejected a petition in which Roche sought to stop a generic drugmaker from selling a cheaper version of an expensive rare disease drug. The move comes after a lower court earlier this month upheld a ruling that it would be in the public interest […]
FDA declares Novo Nordisk drug manufacturing plant non-compliant
A troubled contract manufacturing plant in Indiana recently acquired by Novo Nordisk is considered noncompliant with Food and Drug Administration standards, a serious designation that could further delay approval of drugs made at the facility, including some from Scholar Rock and Regeneron Pharmaceuticals. STAT previously reported that an FDA inspection of the plant over the […]
The Board of Directors of Colorado is moving first in the nation, sets the payment limit on Amgen Drug
In a move from the first per country, a panel of Colorado voted to limit state health plans for costly arthritis treatment, a step that can encourage other states to pursue similar strategies to contain expenditure on prescription medication. The historic vote by the Colorado prescription Drug Approvality Board creates a higher payment limit for […]
The British patient advocates the antitrust regulator to probe drug manufacturers
The UK antitrust regulator was invited by patient defense groups to investigate several major drug manufacturers and their British lobbying organization for “suspects” and “coordinated” efforts to increase the prices of medicines. The backdrop of the complaint was an ongoing row between the pharmaceutical industry and the British government for the compulsory discounts that pharmaceutical […]
The obesity drug of Novo Nordisk Wegovy is eliminated to treat the puree of living diseases
On Friday, the NOVO Nordisk obesity medication was eliminated on Friday by American regulators to treat an increasingly common liver disease, adding to the list of the conditions for which the therapy with superproduction is now approved. Food and Drug Administration has granted accelerated approval to Wegovy for patients with steatohepatitis associated with metabolic dysfunction, […]
Medicines manufacturers are a new group to put pressure on the impact of negotiation of drug prices for medication
Washington – A handful of pharmaceutical companies have trained a group to present to legislators research on what industry considers the negative impacts of negotiations on Medicare drug prices, according to lobbying files. The group is called the IRA watchdog after the law on the reduction of inflation, which ordered Medicare to negotiate the prices […]
SAREPTA is resistant to the FDA on elements, the agency chooses the best drug regulator | Stat
Hello everyone, it’s Jason Mast, filling for Ed. Today, I am at the New York office in Pharmalittle, sipping a Bread’s Bakery coffee, which serves the best Babka in Manhattan. (The best babka in the country, for those who wonder, is that of my mother. She does not take orders, but if you are really, […]
Gilead should provide drug prevention medication in low -income countries
After months of anticipation, Gilead offered an agreement to provide its revolutionary drug on HIV prevention to up to 2 million people in low and intermediate income countries. As part of the New Deal, the Global Fund to combat AIDS, tuberculosis and malaria will be responsible for the purchase and provision of drug doses, known […]
Apogee Therapeutics reports the first data on the drug in long -term eczema
Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54. Apogee Therapeutics said […]